Full-text search

Results for “Pfizer”

Search across the indexed text of every released document.

Names that match “Pfizer”

19 documents found

In a career spanning three decades in academic medicine, Robin Solomon has combined patient care, cl
document IMAGES-003-HOUSE_OVERSIGHT_015671.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… Sinai’s research capabilities. These efforts attracted ongoing contracts from Novartis, Smith Kline Beecham, Amgen and Pfizer and other pharmaceutical and biotech companies. She facilitated over $18 million in grant funding, increased clinical trials by 40% and grew patient enro...

In a career spanning three decades in academic medicine, Robin Solomon has combined patient care, cl
document TEXT-001-HOUSE_OVERSIGHT_015672.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…fusal in phase III clinical trials (with appropriate patient populations) from Novartis, Smith Kline Beecham, Amgen and Pfizer and other pharmaceutical and biotech companies. • Grew research revenue by increasing clinical trials by 40% and patient enrollment by over 320% annually...

George’ s mother: Yeah, but it’ s not me he gets excited over. It’ s
document IMAGES-003-HOUSE_OVERSIGHT_015399.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…’ s apartment. Kramer bursts through the door] Kramer: Jerry! Jerry! I’ m gonna be rich! | bought a bunch of shares in Pfizer when it was real low, and now they put Viagra on the market and all the doctors are getting writers’ cramp from writing prescriptions, and the stock is g...

In a career spanning three decades in academic medicine, Robin Solomon has combined patient care, cl
document TEXT-001-HOUSE_OVERSIGHT_015671.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… Sinai’s research capabilities. These efforts attracted ongoing contracts from Novartis, Smith Kline Beecham, Amgen and Pfizer and other pharmaceutical and biotech companies. She facilitated over $18 million in grant funding, increased clinical trials by 40% and grew patient enro...